Use of vaginal mesh in the face of recent FDA warnings and litigation

Sara J. Mucowski, Catalin Jurnalov, John Phelps

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Choosing to use mesh in vaginal reconstructive surgery for pelvic organ prolapse or stress urinary incontinence is perplexing in the face of recent US Food and Drug Administration (FDA) warnings. In October 2008, the FDA alerted practitioners to complications associated with transvaginal placement of surgical mesh. Litigation is another concern. A Google search of "transvaginal mesh" results in numerous hits for plaintiff attorneys seeking patients with complications related to use of mesh. In light of a recent decision by the US Supreme Court and strategies by manufactures of medical devices to escape liability, it is imperative that gynecologic surgeons using transvaginal mesh document proper informed consent in the medical records. The purpose of this commentary is not to deter gynecologic surgeons from using transvaginal mesh when appropriate, but to provide an overview of current medical-legal controversies and stress the importance of documenting informed consent.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume203
Issue number2
DOIs
StatePublished - 2010

Fingerprint

Jurisprudence
United States Food and Drug Administration
Reconstructive Surgical Procedures
Surgical Mesh
Supreme Court Decisions
Consent Forms
Pelvic Organ Prolapse
Lawyers
Stress Urinary Incontinence
Informed Consent
Medical Records
Equipment and Supplies
Surgeons

Keywords

  • informed consent
  • lawsuit
  • mesh
  • pelvic organ prolapse
  • stress urinary incontinence

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Use of vaginal mesh in the face of recent FDA warnings and litigation. / Mucowski, Sara J.; Jurnalov, Catalin; Phelps, John.

In: American Journal of Obstetrics and Gynecology, Vol. 203, No. 2, 2010.

Research output: Contribution to journalArticle

Mucowski, Sara J. ; Jurnalov, Catalin ; Phelps, John. / Use of vaginal mesh in the face of recent FDA warnings and litigation. In: American Journal of Obstetrics and Gynecology. 2010 ; Vol. 203, No. 2.
@article{960d949c6717401aa274532e087f822a,
title = "Use of vaginal mesh in the face of recent FDA warnings and litigation",
abstract = "Choosing to use mesh in vaginal reconstructive surgery for pelvic organ prolapse or stress urinary incontinence is perplexing in the face of recent US Food and Drug Administration (FDA) warnings. In October 2008, the FDA alerted practitioners to complications associated with transvaginal placement of surgical mesh. Litigation is another concern. A Google search of {"}transvaginal mesh{"} results in numerous hits for plaintiff attorneys seeking patients with complications related to use of mesh. In light of a recent decision by the US Supreme Court and strategies by manufactures of medical devices to escape liability, it is imperative that gynecologic surgeons using transvaginal mesh document proper informed consent in the medical records. The purpose of this commentary is not to deter gynecologic surgeons from using transvaginal mesh when appropriate, but to provide an overview of current medical-legal controversies and stress the importance of documenting informed consent.",
keywords = "informed consent, lawsuit, mesh, pelvic organ prolapse, stress urinary incontinence",
author = "Mucowski, {Sara J.} and Catalin Jurnalov and John Phelps",
year = "2010",
doi = "10.1016/j.ajog.2010.01.060",
language = "English (US)",
volume = "203",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Use of vaginal mesh in the face of recent FDA warnings and litigation

AU - Mucowski, Sara J.

AU - Jurnalov, Catalin

AU - Phelps, John

PY - 2010

Y1 - 2010

N2 - Choosing to use mesh in vaginal reconstructive surgery for pelvic organ prolapse or stress urinary incontinence is perplexing in the face of recent US Food and Drug Administration (FDA) warnings. In October 2008, the FDA alerted practitioners to complications associated with transvaginal placement of surgical mesh. Litigation is another concern. A Google search of "transvaginal mesh" results in numerous hits for plaintiff attorneys seeking patients with complications related to use of mesh. In light of a recent decision by the US Supreme Court and strategies by manufactures of medical devices to escape liability, it is imperative that gynecologic surgeons using transvaginal mesh document proper informed consent in the medical records. The purpose of this commentary is not to deter gynecologic surgeons from using transvaginal mesh when appropriate, but to provide an overview of current medical-legal controversies and stress the importance of documenting informed consent.

AB - Choosing to use mesh in vaginal reconstructive surgery for pelvic organ prolapse or stress urinary incontinence is perplexing in the face of recent US Food and Drug Administration (FDA) warnings. In October 2008, the FDA alerted practitioners to complications associated with transvaginal placement of surgical mesh. Litigation is another concern. A Google search of "transvaginal mesh" results in numerous hits for plaintiff attorneys seeking patients with complications related to use of mesh. In light of a recent decision by the US Supreme Court and strategies by manufactures of medical devices to escape liability, it is imperative that gynecologic surgeons using transvaginal mesh document proper informed consent in the medical records. The purpose of this commentary is not to deter gynecologic surgeons from using transvaginal mesh when appropriate, but to provide an overview of current medical-legal controversies and stress the importance of documenting informed consent.

KW - informed consent

KW - lawsuit

KW - mesh

KW - pelvic organ prolapse

KW - stress urinary incontinence

UR - http://www.scopus.com/inward/record.url?scp=77955652846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955652846&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2010.01.060

DO - 10.1016/j.ajog.2010.01.060

M3 - Article

VL - 203

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 2

ER -